Endometriosis Industry - Current & Future Analysis of Market Competition

1
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017byGlobalData

• Explore all reports for Women's Health
  Therapeutics market
• _at_
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/therapeutics/womens-health-th
  erapeutics .

2
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• Endometriosis is a gynecological disorder
  affecting women of childbearing age. This
  inflammatory condition is characterized by the
  growth of endometrial tissues outside of the
  uterus, and can cause chronic painful
  menstruation, painful intercourse, and
  infertility. For many women, endometriosis-associa
  ted pain can be so debilitating that it affects
  their ability to perform daily functions and
  significantly deters their quality of life.
• The KOLs agree patients with endometriosis have
  significant unmet needs due to the lack of
  approved treatment options that have both
  continuous efficacy and a favorable long-term
  safety profiles. Although the KOLs are optimistic
  about the potential approval of GnRH antagonists,
  they still foresee that unmet needs will persist.
  Being orally active is a major benefit for GnRH
  antagonists. As such research foresees they will
  rapidly shift market share away from GnRH
  agonists. However their price will limit
  penetration in other patient segments.
  Ultimately, since none of the marketed,
  off-label, or pipeline drugs are curative,
  significant opportunity will remain for safe,
  efficacious therapies that target the root cause
  of the condition.
• In 2012, the global market was largely dominated
  by the US, with sales of 1.1bn. Combined sales
  in the 5EU were estimated to be 137.6m. By 2017,
  Research forecasts global endometriosis
  therapeutics sales to grow slowly to 1.2bn at a
  compound annual growth rate (CAGR) of 0.19.
• Inquire for Discount _at_
• http//www.rnrmarketresearch.com/contacts/discount
  ?rname146887 .

3
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• Highlights
• Key Questions Answered
• The endometriosis therapeutics market has had
  weak competition due to a lack of approved
  therapies, and high rates of off-label drug use.
  What are the underlying unmet needs in this
  market? What opportunities will remain after
  elagolix is launched?
• The late-stage pipeline is comprised of GnRH
  antagonists. What sort of impact will these
  therapies have on this market? Which will emerge
  as market leaders? How will these products fare
  against existing therapies?
• The endometriosis therapeutics market has
  considerable unmet needs due to low diagnosis
  rates, minimal disease awareness, and lack of a
  well-tolerated long-term treatment options. Which
  drivers and barriers will affect the market
  landscape? What trends can be expected in each of
  US and 5EU?
• Complete Report Available _at_
• http//www.rnrmarketresearch.com/opportunityanalyz
  er-endometriosis-opportunity-analysis-and-forecast
  s-to-2017-market-report.html .

4
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• Key Findings
• The single most important driver of growth will
  be the launch of novel agents with superior
  safety and more convenient oral formulations
• GnRH agonists will rapidly shift market share
  from GnRH agonists however their price will limit
  penetration in other patient share segments
• Incomplete knowledge regarding disease
  pathogenesis and pathophysiology creates a major
  obstacle in the development of novel therapeutics
• Ultimately, since none of the marketed,
  off-label, and pipeline drugs are curative,
  significant opportunity will remain for safe,
  efficacious therapies that target the root cause
  of the condition.
• Scope
• Overview of endometriosis, including
  epidemiology, etiology, pathophysiology,
  symptoms, diagnosis, and treatment guidelines.
• Annualized endometriosis therapeutics market
  revenue, annual cost of therapy, and top line US
  and 5EU market forecasts from 2012 to 2017.
• Buy a copy of report _at_
• http//www.rnrmarketresearch.com/contacts/purchase
  ?rname146887 .

5
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• Key topics covered include strategic competitor
  assessment, market characterization, unmet needs,
  and implications for the endometriosis
  therapeutics market.
• Pipeline analysis comprehensive data split
  across different phases, emerging novel trends
  under development, and detailed analysis of
  late-stage pipeline drugs.
• Analysis of the current and future market
  competition in the global endometriosis
  therapeutics market. Insightful review of the key
  industry drivers, restraints and challenges. Each
  trend is independently researched to provide
  qualitative analysis of its implications.
• Reasons to buy
• Develop and design your in-licensing and
  out-licensing strategies through a review of
  pipeline products and technologies, and by
  identifying the companies with the most robust
  pipeline. Additionally a list of acquisition
  targets included in the pipeline product company
  list.
• Develop business strategies by understanding the
  trends shaping and driving the global
  endometriosis therapeutics market.
• Buy a copy of report _at_
• http//www.rnrmarketresearch.com/contacts/purchase
  ?rname146887 .

6
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• Formulate effective sales and marketing
  strategies by understanding the competitive
  landscape and by analysing the performance of
  various competitors.
• Identify emerging players with potentially strong
  product portfolios and create effective
  counter-strategies to gain a competitive
  advantage.
• Drive revenues by understanding the key trends,
  innovative products and technologies, market
  segments, and companies likely to impact the
  global endometriosis therapeutics market in
  future.
• Track drug sales in the global endometriosis
  therapeutics market from 2012-2017.
• Organize your sales and marketing efforts by
  identifying the market categories and segments
  that present maximum opportunities for
  consolidations, investments and strategic
  partnerships.
• Complete Report Available _at_
• http//www.rnrmarketresearch.com/opportunityanalyz
  er-endometriosis-opportunity-analysis-and-forecast
  s-to-2017-market-report.html .

7
OpportunityAnalyzer Endometriosis Opportunity
Analysis and Forecasts to 2017

• For more details contact Mr. Priyank Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.